Picture of Surrozen logo

SRZN — Surrozen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Surrozen Presents Data On Two Lead Therapeutic Candidates At United European Gastroenterology (Ueg) Week

Oct 10 (Reuters) - Surrozen Inc  SRZN.O :
    * SURROZEN PRESENTS DATA ON TWO LEAD THERAPEUTIC CANDIDATES
AT
UNITED EUROPEAN GASTROENTEROLOGY (UEG) WEEK
    * SURROZEN - SZN-043 PRECLINICAL DATA SHOWS RAPID, TRANSIENT
INCREASES IN HEPATOCYTE PROLIFERATION & WAS WELL TOLERATED IN
NON-CLINICAL TOXICOLOGY STUDIES
    * SURROZEN INC - SZN-1326 PRECLINICAL DATA SHOWS IMPROVED
INTESTINAL EPITHELIAL HEALING, RESTORED EPITHELIAL BARRIER
    * SURROZEN INC - SZN-1326 PRECLINICAL DATA SHOWS REDUCED
COLITIS-ASSOCIATED COLLAGEN DEPOSITION AND WAS WELL TOLERATED IN
NON-CLINICAL TOXICOLOGY STUDIES

Source text for Eikon:  ID:nGNX2bDrZ3 
Further company coverage:  SRZN.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Surrozen

See all news